InvestorsHub Logo
Followers 15
Posts 1647
Boards Moderated 0
Alias Born 05/15/2015

Re: None

Thursday, 05/26/2016 10:25:27 AM

Thursday, May 26, 2016 10:25:27 AM

Post# of 49606
TPIV: News! TapImmune issued highly valuable T-cell patent.


$TPIV New Patent 9,364,523 is a very valuable Patent for immunologists and has considerable potential to be used directly by TPIV as well as licensed to Major Pharmas currently doing R&D such as BMY, MRK, Roche/Genentech, AZN etc.

TPIV @ .50s now.

Immuno/oncology patent plays are red hot in bio/pharma sector

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.